Visum Pharma
Greenwich, US · Founded 2021 · Delaware corporation
Founders & leadership
PV
Peter VanderklishNamed on SEC filing
WJ
William J GedaleNamed on SEC filing
MS
Mark SmithNamed on SEC filing
BP
Bernard PeperstraeteNamed on SEC filing
JC
John CostantinoNamed on SEC filing
AC
Alex CuomoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2021–2023
▶$50KraisedSep 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$50KraisedSep 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernard PeperstraeteDirector
- Peter VanderklishDirector
- John CostantinoDirector
- Alex CuomoExecutive Officer
- William J GedaleExecutive Officer, Director
- Mark SmithExecutive Officer
- Offering amount
- $300K
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b, 4a5
▶$1.2MraisedNov 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedNov 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter VanderklishDirector
- William J GedaleExecutive Officer, Director
- Mark SmithExecutive Officer
- Bernard PeperstraeteDirector
- John CostantinoDirector
- Alex CuomoExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $1.2M
- Minimum investment
- $100K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Visum Pharma raised?
- Visum Pharma has disclosed $1.3M raised across 2 rounds.
- Where is Visum Pharma headquartered?
- Visum Pharma is headquartered in Greenwich, US.